Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

Collaboration leverages Logica, a platform offering from Valo Health and Charles River that ... partnership between Flagship Pioneering and Pfizer to accelerate discovery of innovative compounds ...

Ph.D., chief operating officer at Valo Health. "Our collaboration gives us access to nference's deep multimodal, longitudinal data and AI software platform, which will allow us to learn through ...

the result of a strategic collaboration between Charles River and Valo Health, is the industry’s first computation-powered, unified target-to-candidate offering. The platform leverages the ...

Research collaboration expedites innovation by leveraging synergies between Valo Health's Opal Computational Platform™ and the nference Agentic AI platform CAMBRIDGE, Mass. & LEXINGTON, ...

“Together with our partners at Valo Health and through our ongoing collaboration with Flagship’s Pioneering Medicines, we look forward to further leveraging the power of Logica to advance this ...